GENFIT
GENFIT, a biopharmaceutical company headquartered in France, is at the forefront of developing innovative therapies for metabolic and liver diseases. Founded in 2008, the company has made significant strides in the industry, particularly with its focus on non-alcoholic steatohepatitis (NASH) and other related conditions. With a robust pipeline of clinical programmes, GENFIT's core products, including its lead candidate elafibranor, are designed to address unmet medical needs in liver health. The company distinguishes itself through its commitment to precision medicine and the integration of advanced biomarkers in its research. Recognised for its expertise, GENFIT has established a strong market position, contributing to the evolving landscape of liver disease treatment. Its dedication to innovation and patient-centric solutions continues to drive its success in the biopharmaceutical sector.
DitchCarbon Score
How does GENFIT's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GENFIT's score of 39 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
GENFIT's reported carbon emissions
In 2023, GENFIT reported total carbon emissions of approximately 756,000 kg CO2e. This figure includes about 663,000 kg CO2e from Scope 1 emissions, which encompass direct emissions from owned or controlled sources, and about 92,000 kg CO2e from Scope 2 emissions, related to purchased electricity. Additionally, Scope 3 emissions, which cover indirect emissions from the value chain, amounted to approximately 804,000 kg CO2e. Comparatively, in 2022, GENFIT's total emissions were about 801,000 kg CO2e, with Scope 1 emissions at approximately 700,000 kg CO2e and Scope 2 emissions at about 101,000 kg CO2e. The Scope 3 emissions for that year were around 776,000 kg CO2e. Looking back further, in 2021, the total emissions were approximately 846,000 kg CO2e, with Scope 1 emissions of about 746,000 kg CO2e, Scope 2 emissions of around 100,000 kg CO2e, and Scope 3 emissions reaching approximately 751,000 kg CO2e. Despite these figures, GENFIT has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of documented reduction strategies suggests a need for further commitment to climate action within the industry context.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 627,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 110,000 | 000,000 | 000,000 | 00,000 |
| Scope 3 | - | 000,000 | 000,000 | 000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
GENFIT is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
